Most Recent Events

20 Oct 2017
Results assessing efficacy and tolerability of cabozantinib [XL 184] in patients with advanced solid tumours, with multi-cohorts of patients with metastatic hormone-refractory prostate cancer, ovarian cancer and breast cancer, were published in the European Journal of Cancer.

26 Jul 2017
Results (N=70) of ovarian carcinoma cohort published in the European Journal of Cancer

10 Jun 2017
Biomarkers information updated

Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

Login
with a username/password associated to an account with a valid subscription